FDA Inspection 934692 — Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. — FEI 3004664441

The FDA completed an inspection of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. on May 15, 2015 in Nanjing. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 15, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Nanjing (China)